Ignite Creation Date:
2024-05-06 @ 3:10 AM
Last Modification Date:
2024-10-26 @ 11:29 AM
Study NCT ID:
NCT02228421
Status:
TERMINATED
Last Update Posted:
2020-03-11
First Post:
2014-08-27
Brief Title:
Study to Evaluate Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
Sponsor:
PeriPharm
Organization:
PeriPharm
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Non-small Cell Lung Cancer Metastatic |
Keywords: